tm
Seeing Is Believing
tm
Seeing Is Believing
Progenics Pharmaceuticals's activity chart (see below) currently has 25 price targets and 19 ratings on display.
Analysts average stock forecasts to be materialized ratio is 38.45% with an average time for these price targets to be met of 130.25 days.
Most recent stock forecast was given by from CAPITAL ONE on 12-Aug-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Aug-2019
$14
$9.9 (241.46%)
$14
7 years 1 months 8 days ago
(12-Aug-2019)
0/2 (0%)
$10.1 (258.97%)
Buy Since 30-Sep-2014
$10
$5.9 (143.90%)
7 years 6 months 6 days ago
(14-Mar-2019)
5/11 (45.45%)
$5.58 (126.24%)
295
Buy
$11
$6.9 (168.29%)
$9
9 years 8 months 9 days ago
(11-Jan-2017)
3/3 (100%)
$2.1 (23.60%)
165
$11
$6.9 (168.29%)
$11
9 years 10 months 26 days ago
(26-Oct-2016)
2/3 (66.67%)
$5.85 (113.59%)
135
Buy Since 06-Aug-2015
$14
$9.9 (241.46%)
$14
10 years 2 months ago
(20-Jul-2016)
1/4 (25%)
$7.86 (128.01%)
76
What is PGNX (Progenics Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on PGNX (Progenics Pharmaceuticals)?
Which analyst has the current lower performing score on PGNX (Progenics Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PGNX (Progenics Pharmaceuticals)?
Which analyst is the currently most bullish on PGNX (Progenics Pharmaceuticals)?
Which analyst is the currently most reserved on PGNX (Progenics Pharmaceuticals)?
